Durvalumab vs Paroxetine

Durvalumab vs Paroxetine: Overview

This comparison examines the pharmacological differences between Durvalumab and Paroxetine.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Paroxetine: Potent selective serotonin reuptake inhibitor with additional muscarinic and NE reuptake inhibition.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Paroxetine — 21 hours.

Chemical Properties

Molecular Formula: Paroxetine — C19H20FNO3.

Molecular Weight: Paroxetine — 329.3730 g/mol.

Type: Durvalumab — Antibody; Paroxetine — Small molecule.